Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
PHARMA - RABIES CASES IN GERMANY

Germany set to stop rabies crossing borders

 

BY OUR PHARMA CORRESPONDENT

12th August 2005: As the increase in the wildlife rabies threatened to cross borders, Germany has recently tightened its vaccination strategy. France, one of its neighboring countries, had severely criticized Germany for its apparent inaction in containing the spread of rabies.

The country experienced a surge in rabies cases in the last quarter of last year and first quarter of this year, causing fear in neighboring France, Belgium, Luxembourg and Switzerland, each of which had succeeded in eradicating wildlife rabies in recent years.

Germany's National Reference Laboratory for Rabies, based at the Friedrich-Loeffler-Institute's Federal Research Institute for Animal Health expressed hope that the planned vaccination efforts might result in the eradication of rabies in Germany.
According to the World Health Organization's Rabies Bulletin, Europe, in the last quarter of 2004, there were 23 cases of rabies (16 foxes, 3 roe deer, 4 bats) reported in Germany, up from 15 (7 foxes, 1 badger, 7 bats) the previous quarter. In the first quarter of this year, 25 cases (1 horse, 1 roe deer, 23 foxes) were reported, and in the second quarter only 11 cases (2 bats, 9 foxes) were reported.

The rabies cases in the second quarter of this year exclusively occurred in the hot spot areas in the border area between Hesse and Rhineland Palatinate. France and the other western neighboring countries were and still are outside the danger zone, Germany's National Reference Laboratory for Rabies said.

Earlier, Germany focused its vaccination efforts on relatively low fox densities in rural settings, although the disease in Germany had moved to suburban and urban areas with very high fox densities. "This is a phenomenon no other country in Europe was confronted with," it noted.
In early May, Florence Cliquet, director of the rabies laboratory of Agence Française de Sécurité Sanitaire des Aliments in Nancy, suggested that Germany had failed to adapt its control efforts to recommendations for oral vaccinations of foxes issued in 2002 by the European Union. She said: "From my point of view, the tools, the means, are available to combat rabies. Probably Germany does not use the tools very well."

He said a lack of cooperation between state rabies agencies had also been a problem, but since the beginning of the year the National Reference Laboratory for Rabies at the Friedrich-Loeffler-Institute has been "much more deeply involved in the planning, management, and evaluation of the vaccination campaigns than before." All involved agencies now meet every six months under the auspices of the National Reference Laboratory for Rabies.

BY OUR PHARMA CORRESPONDENT

Pharma News Headlines

Cancer News

Cardiac News

US FDA News

Pharma industry news

LATEST UPDATES

Heart disease deaths more among New Yorkers

Pfizer to offer drugs risk/benefit summary to consumers 

Merck lied to public on Vioxx: lawyer tells jurors

Novartis acquires rights of kidney dialysis drug from SeBo

J&J's Concerta approved treatment of ADHD in teenagers in Canada

US FDA stalls Roche’ Accutane use in pregnancy

Novo Nordisk, Eli Lilly remove insulin products from Australia

British drug supply chain safety questioned after another fake Lipitor find

Wyeth starts support programme for Effexor patients

P&G’s Actonel with Calcium approved for osteoporosis

Pozen gets patent on pain management product

Genmab studies new drug for rheumatoid arthritis

Painkillers may increase blood pressure: study

Nektar buys out Aerogen for $32 m

Predix records positive data on anxiety drug

Insmed files against Increlex approval

Hepatitis A vaccine for kids approved in US

Psoriasis drug data positive: Cytochroma

Novo Nordisk’s 24-hour acting insulin Levemir gets US FDA okay

US FDA approves Teva's generic for osteoporosis 

Pfizer files NDA for Sutent in US

BioVeris licenses Baxter's vaccine portfolio

TheraQuest receives 2nd Orphan Drug status for neuralgia drug

Real-time glucose monitoring device approved in US

Halozyme gets FDA nod for bladder cancer therapy

Migenix to commence phase 2b studies in hep C therapy

Barr gets US FDA okay for clonazepam tabs

Anorexia drug study results positive: Par

GlaxoSmithKline begins phase III trials of new HIV drug

Ranbaxy's 7 anti retrovirals included in WHO list

FDA tightens restrictions on acne drug

Voglibose tabs launched in Japan

Remicade researcher gifts $ 105m to NYU

Par loses ondansetron case to GSK

Mistral starts clinical studies for generic

Carl Icahn sells Mylan shares

Florida sues Mylan, Teva and Watson

Dey and Connecticut settle pricing dispute

Germany set to stop rabies crossing borders

Office to review DTC drug advertisements in US

British docs to be trained in communication, safety

FDA okays acrylic lens for cataract patients 

Corautus to go ahead with angina drug studies 

Americans turn the low-fat way

Chemicals in plastics pose danger

US committee probes doctors’ complicity with Wall Street analysts

Meda buys out rival Viatris

US FDA nod for new levofloxacin regimen to treat acute bacterial sinusitis

Pozen files for new migraine treatment

New therapy for pancreatic cancer under review

New device inducing blood flow to heart granted US patent

NIH announces grants for faster, cheaper DNA sequencing

DOV starts phase III trial of pain drug in US

Alcohol linked cancers: Acetaldehyde in spot light

Hypertension `just above normal’ too risky

Gene causes infertility drugs go awry: study

China’s pig flu outbreak

Cardiac Science-Defibtech lawsuit settled

Peregrine starts Phase-1 anti-viral trial of Tarvacin

Dr. Reddy's launches immune booster for children

Lupin in pact with Kyowa of Japan

Bird flu vaccine may work in humans: US researchers

 

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us